SRD5A1 and prostate carcinoma: Using the Cancer Cell Line Encyclopedia (CCLE) RNA-seq data of human prostate cancer cell lines, 22Rv1, DU145, LNCaP, MDA PCa 2b, NCI-H660, PC-3, and VCaP, we observed that, compared with SHBG, which is endogenously not expressed, SRD5A1 is significantly upregulated in recurrent and metastatic PCa cell lines (Figure 5A).